• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

CDKL3 通过激活 PI3K/Akt/mTOR 通路抑制自噬促进非小细胞肺癌。

CDKL3 Promotes Non-small Cell Lung Cancer by Suppressing Autophagy Via Activation of PI3K/Akt/mTOR Pathway.

机构信息

Department of Radiotherapy, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, 710061, Shanxi, China.

Department of Cardiology, The Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an, 710061, Shanxi, China.

出版信息

Mol Biotechnol. 2023 Sep;65(9):1421-1431. doi: 10.1007/s12033-023-00656-8. Epub 2023 Jan 11.

DOI:10.1007/s12033-023-00656-8
PMID:36630073
Abstract

This study aimed to assess the role of cyclin-dependent kinase-like 3 (CDKL3) in the progression of non-small cell lung cancer (NSCLC) as well as the underlying mechanisms. Western blot and qRT-PCR were utilized to analyze CDKL3 expression in 30 pairs of NSCLC and paraneoplastic tissues. A549 cells with CDKL3 knockdown and PC9 cells with CDKL3 overexpression were constructed by infecting cells with lentiviruses expressing shRNA of CDKL3 and expressing a full-length CDKL3 mRNA, respectively. The CCK-8 assay, flow cytometry, wound healing assay, and Transwell assay were carried out to detect cell viability, apoptosis, migration, and invasion, respectively. Autophagosome morphology was observed by electron microscopy experiments, the expression of key components of the PI3K/Akt/mTOR pathway was examined via Western blot and their mRNA expression levels were determined. Besides, the stably infected NSCLC cells with reduced expression or overexpression of CDKL3 were inoculated into the right-back flank of mice to generate tumors. The results showed that CDKL3 expression was dramatically increased in NSCLC tissues. Moreover, CDKL3 promoted the viability and migration of NSCLC cells by suppressing autophagy in vitro and in vivo. In addition, CDKL3 might modulate PI3K/Akt/mTOR signaling in NSCLC. Overall, CDKL3 might promote NSCLC cell viability and metastasis by inhibiting autophagy and activating the PI3K/Akt/mTOR signaling pathway.

摘要

本研究旨在评估周期素依赖性激酶样 3(CDKL3)在非小细胞肺癌(NSCLC)进展中的作用及其潜在机制。通过Western blot 和 qRT-PCR 分析了 30 对 NSCLC 和癌旁组织中 CDKL3 的表达。通过感染表达 shRNA 的慢病毒和表达全长 CDKL3 mRNA 的慢病毒,构建了 CDKL3 敲低的 A549 细胞和 CDKL3 过表达的 PC9 细胞。通过 CCK-8 测定、流式细胞术、划痕愈合实验和 Transwell 实验分别检测细胞活力、细胞凋亡、迁移和侵袭。通过电子显微镜实验观察自噬体形态,通过 Western blot 检测 PI3K/Akt/mTOR 通路关键组成部分的表达,并测定其 mRNA 表达水平。此外,将 CDKL3 表达降低或过表达的稳定感染 NSCLC 细胞接种到小鼠右后背部以生成肿瘤。结果表明,CDKL3 在 NSCLC 组织中表达显著增加。此外,CDKL3 通过抑制自噬在体外和体内促进 NSCLC 细胞的活力和迁移。此外,CDKL3 可能在 NSCLC 中调节 PI3K/Akt/mTOR 信号通路。总的来说,CDKL3 可能通过抑制自噬和激活 PI3K/Akt/mTOR 信号通路来促进 NSCLC 细胞的活力和转移。

相似文献

1
CDKL3 Promotes Non-small Cell Lung Cancer by Suppressing Autophagy Via Activation of PI3K/Akt/mTOR Pathway.CDKL3 通过激活 PI3K/Akt/mTOR 通路抑制自噬促进非小细胞肺癌。
Mol Biotechnol. 2023 Sep;65(9):1421-1431. doi: 10.1007/s12033-023-00656-8. Epub 2023 Jan 11.
2
SIRT6 through PI3K/Akt/mTOR signaling pathway to enhance radiosensitivity of non-Small cell lung cancer and inhibit tumor progression.SIRT6 通过 PI3K/Akt/mTOR 信号通路增强非小细胞肺癌的放射敏感性并抑制肿瘤进展。
IUBMB Life. 2021 Sep;73(9):1092-1102. doi: 10.1002/iub.2511. Epub 2021 Jun 4.
3
Kaempferol promotes non-small cell lung cancer cell autophagy via restricting Met pathway.山奈酚通过抑制 Met 通路促进非小细胞肺癌细胞自噬。
Phytomedicine. 2023 Dec;121:155090. doi: 10.1016/j.phymed.2023.155090. Epub 2023 Sep 16.
4
Effect of microRNA-135a on Cell Proliferation, Migration, Invasion, Apoptosis and Tumor Angiogenesis Through the IGF-1/PI3K/Akt Signaling Pathway in Non-Small Cell Lung Cancer.微小RNA-135a通过IGF-1/PI3K/Akt信号通路对非小细胞肺癌细胞增殖、迁移、侵袭、凋亡及肿瘤血管生成的影响
Cell Physiol Biochem. 2017;42(4):1431-1446. doi: 10.1159/000479207. Epub 2017 Jul 17.
5
SSPH I, A Novel Anti-cancer Saponin, Inhibits EMT and Invasion and Migration of NSCLC by Suppressing MAPK/ERK1/2 and PI3K/AKT/ mTOR Signaling Pathways.SSPH I,一种新型抗癌皂苷,通过抑制 MAPK/ERK1/2 和 PI3K/AKT/mTOR 信号通路抑制非小细胞肺癌的 EMT 和侵袭迁移。
Recent Pat Anticancer Drug Discov. 2024;19(4):543-555. doi: 10.2174/0115748928283132240103073039.
6
ROR1-AS1 knockdown inhibits growth and invasion and promotes apoptosis in NSCLC cells by suppression of the PI3K/Akt/mTOR pathway.ROR1-AS1 knockdown 通过抑制 PI3K/Akt/mTOR 通路抑制非小细胞肺癌细胞的生长、侵袭并促进其凋亡。
J Biochem Mol Toxicol. 2021 May;35(5):e22726. doi: 10.1002/jbt.22726. Epub 2021 Jan 24.
7
Antiproliferative Activity of Carnosic Acid is Mediated via Inhibition of Cell Migration and Invasion, and Suppression of Phosphatidylinositol 3-Kinases (PI3K)/AKT/Mammalian Target of Rapamycin (mTOR) Signaling Pathway.迷迭香酸通过抑制细胞迁移和侵袭以及抑制磷脂酰肌醇 3-激酶(PI3K)/蛋白激酶 B(AKT)/哺乳动物雷帕霉素靶蛋白(mTOR)信号通路发挥抗增殖作用。
Med Sci Monit. 2019 Oct 21;25:7864-7871. doi: 10.12659/MSM.917735.
8
Morphine promotes non-small cell lung cancer progression by downregulating E-cadherin via the PI3K/AKT/mTOR pathway.吗啡通过 PI3K/AKT/mTOR 通路下调 E-钙黏蛋白促进非小细胞肺癌进展。
Sci Rep. 2024 Sep 10;14(1):21130. doi: 10.1038/s41598-024-72198-1.
9
LncRNA MALAT1 promotes migration and invasion of non-small-cell lung cancer by targeting miR-206 and activating Akt/mTOR signaling.长链非编码RNA MALAT1通过靶向miR-206并激活Akt/mTOR信号通路促进非小细胞肺癌的迁移和侵袭。
Anticancer Drugs. 2018 Sep;29(8):725-735. doi: 10.1097/CAD.0000000000000650.
10
MicroRNA-92a promotes epithelial-mesenchymal transition through activation of PTEN/PI3K/AKT signaling pathway in non-small cell lung cancer metastasis.微小 RNA-92a 通过激活 PTEN/PI3K/AKT 信号通路促进非小细胞肺癌转移中的上皮-间充质转化。
Int J Oncol. 2017 Jul;51(1):235-244. doi: 10.3892/ijo.2017.3999. Epub 2017 May 16.

引用本文的文献

1
CK1δ/ε inhibition induces ULK1-mediated autophagy in tumorigenesis.细胞周期蛋白依赖性激酶1δ/ε抑制在肿瘤发生过程中诱导ULK1介导的自噬。
Transl Oncol. 2024 Feb;40:101863. doi: 10.1016/j.tranon.2023.101863. Epub 2024 Jan 6.

本文引用的文献

1
EGFR-Dependent Extracellular Matrix Protein Interactions Might Light a Candle in Cell Behavior of Non-Small Cell Lung Cancer.表皮生长因子受体(EGFR)依赖的细胞外基质蛋白相互作用可能为非小细胞肺癌的细胞行为带来一线希望。
Front Oncol. 2021 Dec 15;11:766659. doi: 10.3389/fonc.2021.766659. eCollection 2021.
2
Effect of fluconazole on the pharmacokinetics of fuzuloparib: an open-label, crossover study in Chinese healthy male volunteers.氟康唑对呋咱帕利在中国健康男性志愿者体内药代动力学的影响:一项开放标签、交叉研究。
Cancer Chemother Pharmacol. 2022 Jan;89(1):141-148. doi: 10.1007/s00280-021-04376-1. Epub 2021 Dec 1.
3
PDRG1 promotes the proliferation and migration of GBM cells by the MEK/ERK/CD44 pathway.
PDRG1 通过 MEK/ERK/CD44 通路促进 GBM 细胞的增殖和迁移。
Cancer Sci. 2022 Feb;113(2):500-516. doi: 10.1111/cas.15214. Epub 2021 Dec 5.
4
Metformin inhibits the proliferation of canine mammary gland tumor cells through the AMPK/AKT/mTOR signaling pathway .二甲双胍通过AMPK/AKT/mTOR信号通路抑制犬乳腺肿瘤细胞的增殖。
Oncol Lett. 2021 Dec;22(6):852. doi: 10.3892/ol.2021.13113. Epub 2021 Oct 26.
5
CircTP53 promotes colorectal cancer by acting as a miR-876-3p sponge to increase cyclin-dependent kinase-like 3 expression.环状 RNA TP53 通过作为 miR-876-3p 的海绵来增加周期蛋白依赖性激酶样 3 的表达,从而促进结直肠癌的发生。
Cell Signal. 2021 Feb;78:109845. doi: 10.1016/j.cellsig.2020.109845. Epub 2020 Nov 21.
6
CDKL3 Targets ATG5 to Promote Carcinogenesis of Esophageal Squamous Cell Carcinoma.细胞周期蛋白依赖性激酶样 3(CDKL3)靶向自噬相关蛋白 5(ATG5)以促进食管鳞状细胞癌的发生发展。
Front Oncol. 2020 Aug 21;10:1602. doi: 10.3389/fonc.2020.01602. eCollection 2020.
7
Immunoglobulin expression in the endoplasmic reticulum shapes the metabolic fitness of B lymphocytes.内质网中免疫球蛋白的表达塑造了 B 淋巴细胞的代谢适应性。
Life Sci Alliance. 2020 Apr 27;3(6). doi: 10.26508/lsa.202000700. Print 2020 Jun.
8
Hypoxia-induced ARHGAP26 deficiency inhibits the proliferation and migration of human ductus arteriosus smooth muscle cell through activating RhoA-ROCK-PTEN pathway.缺氧诱导的 ARHGAP26 缺乏通过激活 RhoA-ROCK-PTEN 通路抑制人动脉导管平滑肌细胞的增殖和迁移。
J Cell Biochem. 2019 Jun;120(6):10106-10117. doi: 10.1002/jcb.28294. Epub 2018 Dec 28.
9
Suppressing autophagy enhances disulfiram/copper-induced apoptosis in non-small cell lung cancer.抑制自噬可增强二硫化硒/铜诱导的非小细胞肺癌细胞凋亡。
Eur J Pharmacol. 2018 May 15;827:1-12. doi: 10.1016/j.ejphar.2018.02.039. Epub 2018 Mar 13.
10
PI3K-AKT-mTOR inhibition in cancer immunotherapy, redux.癌症免疫治疗中的 PI3K-AKT-mTOR 抑制:再探
Semin Cancer Biol. 2018 Feb;48:91-103. doi: 10.1016/j.semcancer.2017.04.015. Epub 2017 May 2.